Expressions of IGF1,IGF1R,IGFBP3 and their relationship with biological behavior of epithelial ovarian cancer

Gao Hua,Xu Yanping,Liu Qiang
DOI: https://doi.org/10.13283/j.cnki.xdfckjz.2009.07.015
2009-01-01
Abstract:Objective:To study the expressions and the clinical significance of IGF1,IGF1R and IGFBP3 in epithelial ovarian cancer(EOC).Methods:The expressions of IGF1,IGF1R and IGFBP3 were detected by immunohistochemistry in 10 normal ovarian tissues,13 benign epithelial tumors,12 borderline epithelial tumors and 50 EOC,and the relationship with the clinicopathologic characteristics of EOC was further studied.Results:The positive rates of IGF1 expression in normal ovarian tissues,benign epithelial tumors,borderline epithelial tumors and EOC,were 20.00%,23.08%,25.00% and 80.00% respectively.The positive rates of IGF1R expression were 20.00%,30.77%,33.33% and 84.00%.The positive rates of IGFBP3 expression were 30.00%,38.46%,41.67% and 86.00%.The expressions of IGF1,IGF1R and IGFBP3 in EOC were significantly higher than those in borderline epithelial tumors(P<0.01).There was positive correlation between the expression level of IGFIR and pathological grade,FIGO stage and free cancer cells in ascites or peritoneal washes of EOC(P<0.05).There was positive correlation between IGF1R and IGF1 and negative correlation between IGFBP3 and FIGO stage of EOC(P<0.05).Conclusion:Overexpressions of IGF1,IGF1R and IGFBP3 may play important roles in the development and progression of EOC.IGF1R is an attractive target antitumor therapy for epithelial ovarian cancer.
What problem does this paper attempt to address?